Collins Foods has announced that Bronwyn Morris will retire as an independent non-executive director of the company at the conclusion of the Annual General Meeting to be held on Friday 2 September.
Morris, who has served as an independent non-executive director on the company since the listing of Collins Foods, will retire by rotation and will not seek re-election. Additionally, the role of chair of the Audit and Risk Committee will transition to Christine Holman.
In announcing Morris’ retirement, Collins Foods chairman, Robert Kaye, said: “Over the past 11 years, Bronwyn has been a dedicated and valued member of the Board and has expertly led the Audit and Risk Committee through the growth of Collins Foods from its listing to being an ASX 200 company today.
“From her experience as a former partner of KPMG and her wealth of experience gained over 27 years as a company director on numerous organisations, Bronwyn has made a substantial contribution to the governance of Collins Foods, including as a member of Remuneration and Nomination Committee. As chair of the Audit and Risk Committee, Bronwyn has deftly overseen the activities of the Committee, importantly adding significant value to the Group’s financial reporting and risk management functions.
“In addition, she was a member of the Remuneration and Nomination Committee that has overseen two successful internal CEO succession plans. Bronwyn retires with distinction and the Board extends its sincere thanks for her exemplary service to Collins Foods.”
Holman was appointed an independent non-executive director and member of the Audit and Risk Committee and Remuneration and Nomination Committee of the company in 2019. She brings more than 20 years’ of extensive commercial and Board experience across a variety of areas including mergers and acquisitions, finance, sales, technology, digital transformations, and marketing.
“Christine has added valuable insight to the function of the Board, Audit and Risk Committee and Remuneration and Nomination Committee since her appointment to Collins Foods,” Kaye said.
“Her considerable experience and skills make her a natural choice to succeed Bronwyn as chair of the Audit and Risk Committee.”